TAO Connect Opens Mental Health Resources to the Public at No Cost to Assist With the Effects of COVID-19
UF startup and UF Innovate | The Hub graduate TAO Connect, a digital platform designed to make behavioral health therapy more accessible and effective, announced the offering of a free online help session specific to COVID-19, in addition to opening up its entire suite of mindfulness meditation exercises to the public. Both programs are free […]
Full Interview: Algernon Pharmaceuticals Announces Regulatory Submission for COVID-19 Trial in South Korea
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive Vancouver to discuss another development for their repurposed drug Ifenprodil. Moreau provides an update about the clinical study which will consist of 40 patients and will deal with those currently sick with COVID-19. Learn more about Full Interview: […]
SharpSpring Releases First-of-Its-Kind CRM-Integrated Video Calling and Screen Sharing to Address COVID-19
UF startup SharpSpring, Inc., a leading cloud-based marketing and sales automation platform, announced the release of integrated video calls, a free solution for SharpSpring customers, built to help marketing agencies and SMBs connect with leads, contacts, and clients, mimicking an in-person experience. “While Zoom, Slack, Skype, and other services have been amazing for us, SharpSpring […]
UF-Led Ventilator Design Clears First FDA Review
A ventilator envisioned by a University of Florida engineer and built with do-it-yourself parts gained first-step FDA authorization this week, offering hope that it could be in use within weeks at hospitals around the world where COVID-19 patients have overwhelmed supplies of traditional medical equipment. The ventilator, composed of parts readily available for less than […]
Military Drone Maker, Altavian, Is Churning Out N95 Masks for COVID-19 Response
UF startup Altavian, a drone maker that supplies the US military, has shifted some of its production to a new kind of N95-grade mask to be used by medical personnel on the frontlines of America’s latest battle—the COVID-19 emergency response. In fact, the new masks may even exceed the protection of traditional N95 models. The […]
Full Interview: Algernon Pharmaceuticals Updates Phase 2 Human Testing of Ifenprodil for COVID-19
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joins Steve Darling from Proactive Vancouver to provide an update about its initiated phase 2 clinical study of NP-120 for COVID-19 on infected patients in South Korea. Learn more about Full Interview: Algernon Pharmaceuticals Updates Phase 2 Human Testing of Ifenprodil for […]
UF Innovate Launches COVID-19 Resource Section on Website
The new dedicated section offers tools for researchers and startups during the COVID-19 pandemic. As part of UF Innovate’s continuous commitment to inform, it has introduced a COVID-19 Resource Section on the organization’s website. The new page is a comprehensive collection of various tools for researchers and startups, including links to available grants, collaborative efforts, […]
UF Health Researchers Donate Gloves, Masks and Other PPE to Support Frontline Colleagues
Researchers from across the University of Florida and UF Health have joined an urgent effort to collect and donate personal protective equipment, or PPE, to build upon existing stockpiles in support of clinical colleagues on the frontlines of treating COVID-19. By the pallet and truckload, laboratory teams spanning across UF’s many scientific disciplines are amassing […]
UF Plant and Soil Diagnostic Labs Essential to Florida Agriculture, Economy During COVID-19
In the time of COVID-19, plants still get sick, and the soil that nourishes them needs care. The health of plants and soil is critical to agriculture, an industry designated an essential service in response to the pandemic. That’s why when many American universities have transitioned to online-only and their employees adapt to working from […]
Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in Australia for its planned Phase 2 study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough. Ethics submission is the next step in the company’s clinical development program […]